LABD

Direxion Daily S&P Biotech Bear 3x Shares

Down$17.84
$-0.14
(-0.78%)
As of 5:10:00 PM EDT | 11/18/19  |  Market Closed

LABD Trading Data

Open

$17.97

Low Price

$17.73

High Price

$18.39

Previous Last Price

$17.98

Bid Size

$17.85 X 300

Ask Size

$17.91 X 900

LABD Portfolio Data

AUM

$93,559,100

Shares

4,985

PE Ratio

0

Price / Book Ratio

Expense Ratio

1.11

Net Asset Value

$18.77

Volume

Volume

1,816,473

Avg. Volume (YDT)

3,228,568

Dollar Volume

$31,444,732

Weekly Avg. Volume

2,062,374

Monthly Avg. Volume

2,099,763

Quarterly Avg. Volume

2,118,800

LABD Fund Description

The Direxion Daily SP Biotech Bull and Bear 3x Shares seek daily investment results, before fees and expenses, of 300% or 300% of the inverse of the performance of the SP Biotechnology Select Industry Index. There is no guarantee the funds will meet their stated investment objectives.

LABD Chart

LABD Summary

Fund Family

Direxion Investments

Tracks This Index

Direxion Daily S&P Biotech Bear 3x Shares

Inception Date

2015-05-29

Asset Class

Portfolio-Multi Asset

Asset Class Size

Biotech

LABD Classification

Region (General)

Global

Region (Specific)

Sector

Equity Index

Leveraged Family

LABD Technicals

Alpha

23.34

Beta

-5.65

Leverage

Triple-Short

Standard Deviation

7.11

LABD Dividends

Dividend Date

2019-09-24

Latest Dividend

0.059

Annual Dividend

0.39

Annual Dividend Rate

0.39

Annual Dividend Yield

2.09

LABD Performance

YTD Return

-58.3%

1 Year Return

-50.83%

3 Year Return

-87.69%

5 Year Return

0%

10 Year Return

-95.33%

LABD Related Articles

5 Leveraged ETFs For Q2 Of 2019

5 Leveraged ETFs For Q2 Of 2019

With market volatility on the rise due to heightened tensions from the U.S. trade beef with China, Brexit negotiations, and…

© 2019 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.